CAS: 327031-55-0
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
VLX600 REF: IN-DA01BIWHCAS: 327031-55-0 | 100% | To inquire | Tue 07 Jan 25 | |
VLX600 REF: TM-T8500CAS: 327031-55-0 | 100% | 52.00 €~422.00 € | Mon 13 Jan 25 | |
VLX600 REF: TR-V757175CAS: 327031-55-0 | - - - | 92.00 €~1,640.00 € | Fri 14 Feb 25 | |
VLX600 REF: 3D-CNA03155CAS: 327031-55-0 | Min. 95% | To inquire | Tue 18 Feb 25 |
Ref: IN-DA01BIWH
1mg | 67.00 € | ||
5mg | 127.00 € | ||
10mg | 149.00 € | ||
25mg | 313.00 € | ||
50mg | 497.00 € | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
VLX600
CAS:327031-55-0
VLX600 is an iron-chelating oxidative phosphorylation (OXPHOS) inhibitor, is a cell-permeable anticancer agent.
Formula:
C17H15N7
Purity:
100%
Color and Shape:
Solid
Molecular weight:
317.35
Ref: TM-T8500
5mg | 52.00 € | ||
10mg | 84.00 € | ||
25mg | 154.00 € | ||
50mg | 247.00 € | ||
100mg | 422.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
VLX600
Controlled ProductCAS:327031-55-0
Applications VLX600 is a compound showing cytotoxicity against cancer cells. Selective towards malignant cells and …
Formula:
C17H15N7
Color and Shape:
Neat
Molecular weight:
317.35
Ref: TR-V757175
1mg | 92.00 € | ||
10mg | 245.00 € | ||
100mg | 1,640.00 € |
Estimated delivery in United States, on Friday 14 Feb 2025
VLX600
CAS:327031-55-0
VLX600 is a mitochondria-targeted oxidative phosphorylation inhibitor that has been shown to inhibit the growth …
Formula:
C17H15N7
Purity:
Min. 95%
Molecular weight:
317.35 g/mol
Ref: 3D-CNA03155
25mg | To inquire | ||
250mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025